Home Dialysis News

A meta-analysis of studies between 2000 and 2020 revealed a “substantially high” percent of patients on hemodialysis do not adhere to diet and fluid restrictions.

Although the COVID-19 antibody and immune responses were delayed in patients on dialysis, their responses were “substantially stronger” to the Moderna vaccine than the Pfizer-BioNTech vaccine.

Physicians should avoid judging patient adherence to dialysis based on their potassium or phosphorus levels, according to data recently published in Kidney Medicine.

In an interview with Nephrology News & Issues, Cynthia Delgado, MD, FASN, said the first report on the inclusion of race in eGFR was published 22 years ago following the results of the Modification of Diet in Renal Disease Study.

The Peritoneal Dialysis Outcomes and Practice Patterns Study is the largest international prospective cohort study of peritoneal dialysis and related outcomes, providing findings to help inform improvements in peritoneal dialysis care.

Following the 2011 Medicare prospective payment reform for dialysis services, racial disparities have persisted among patients using home dialysis in the U.S., according to a speaker at ASN Kidney Week.

AstraZeneca has been granted fast track designation in the U.S. for the development of Lokelma, according to a company press release.

Those on dialysis or who have previously received a kidney transplant face a higher risk for COVID-19-related death after infection due to the way the virus amplifies these patients’ already intense immunophenotypic alterations.

Implementing evidence-based prevention practices across the nephrology community may be a solution to limiting peritoneal dialysis infections, according to a speaker at ASN Kidney Week.

Panelists opened 2021 ASN Kidney Week by discussing the impact that the COVID-19 virus can have on chronic kidney disease, in addition to how vaccinating vulnerable populations is the best way to end the pandemic.